Clinical Trial Update: Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating apatinib plus etoposide as maintenance therapy after first-line chemotherapy in extensive-stage small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Etoposide (Etoposide)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Extensive-stage Small Cell Lung Cancer, Lung Cancer | Phase 2 | Status: UNKNOWN